Randomized Study Evaluating the Effect of Danirixin on Neutrophil Extracellular Traps (NETs) in Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT03250689 · TERMINATED
Trial details
- NCT number
- NCT03250689
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-15
- Primary completion
- 2018-10-08
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.